Form 8-K - Current report:
SEC Accession No. 0001193125-25-270020
Filing Date
2025-11-06
Accepted
2025-11-06 16:57:12
Documents
15
Period of Report
2025-11-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d37543d8k.htm   iXBRL 8-K 26105
2 EX-5.1 d37543dex51.htm EX-5.1 9203
6 GRAPHIC g37543dsp01.jpg GRAPHIC 4075
7 GRAPHIC g37543g1104072224689.jpg GRAPHIC 1210
  Complete submission text file 0001193125-25-270020.txt   160715

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxrx-20251106.xsd EX-101.SCH 2842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrx-20251106_lab.xml EX-101.LAB 17992
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrx-20251106_pre.xml EX-101.PRE 11255
18 EXTRACTED XBRL INSTANCE DOCUMENT d37543d8k_htm.xml XML 3685
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 251459343
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)